- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03021863
How Frequently and in What Format Are Research Trial Results Disseminated to Participants (ResponseQT) (ResponseQT)
How Frequently and in What Format Are Research Trial Results Disseminated to Participants? A Survey of Trialists and Response Questionnaire Trial
Questionnaires are frequently used in online research, however recruiting, and completion rates of online participants from a variety of cultures and demographic backgrounds can be challenging. The challenge is greater in an online cohort because there is no way to observe the participant beyond what is contributed online. Poor recruiting and completion can result in underpowered research that may not be representative of the sample population. This can trigger an increase in costs as the recruitment period may have to be extended until sample size is reached. When recruiting and completion rates are inadequate studies may have to be terminated and the answer to the research question can remain unknown.
To mitigate these challenges, reminder emails are sent to questionnaire respondents. There is uncertainty about how the tone of the email reminder affects the proportion of recruitment rates.
A nested randomized trial will be used to test the intervention of tone delivery in survey email reminders to establish an evidence base. This study (ResponseQT) proposes to link with the anticipated 20,000 person international cohort study, (How Frequently and in What Format are Research Trial Results Disseminated to Participants: A Survey of Trialists (ResponseQT) to explore the evidence of effect for the research question, "Does the tone of a survey email reminder affect the proportion of survey participants recruited. The population will consist of researchers who have published a clinical trial indexed in Pub Med in 2014-15.The intervention is the tone of questionnaire email reminders and the outcomes will be the proportion of participants recruited after invitation (partial plus complete responses) following reminder 1 and 2.
Study Overview
Status
Conditions
Detailed Description
RATIONALE
Dissemination is the planned process by which results of studies are communicated to the stakeholders of that research. Stakeholders can include health policy makers, academics, practicing clinicians and other health service workers, patients, the general public, and research funders. There are multiple ways to disseminate research findings and it is often considered a shared responsibility between funders and research investigators. Traditionally, the focus has targeted healthcare professionals, policy makers, and academics through journal publications and conference presentations. However, optimal knowledge translation depends on disseminating results to all stakeholders in a way that enables them to consider the implications of the results.
Effective communication and active dissemination of research results to patients and the lay public is essential for making informed decisions and choices, but it is sometimes considered as an afterthought. Furthermore, there is no consensus on what dissemination to patients or members of the lay public means, what is the most effective dissemination process and whether research results should be disseminated to relevant patient groups and the wider public as well as the patients who took part in the studies.
Only clinical trials indexed in PubMed 2014-15 where participants were enrolled into the study will be included. We will include screening questions at the start of the survey to exclude authors of non-randomised controlled trials, preclinical, and first-in-human trials and trials where there were no study participants.
AIM
To identify frequency and format of dissemination of clinical trial results to participants and to identify barriers to dissemination.
OBJECTIVES
- To identify frequency of dissemination of recently published clinical trial results to participants;
- To explore the format of results disseminated to participants and describe researchers' perceived appropriateness and accessibility of the format;
- To identify how frequently research results are disseminated to patients beyond those taking part in the trials such as via advocacy groups;
- To explore the frequency of public/patient involvement for determining the format, content, and extent of the dissemination plans;
- To determine researchers' perceived confidence in disseminating results to participants and other patients.
This research will contain a study within a study (SWAT) also known as a nested trial (ResponseQT).
SWAT RATIONALE
Written communication in questionnaire email reminders are without verbal or sensory cues and it is difficult to modify reminders without feedback from respondents. It would be helpful to know what kind of tone the researcher can take to increase recruitment rates.
In questionnaires, the tone could be perceived as the perception of the researcher's attitude toward the reader and the subject of the message. The overall tone of a questionnaire reminder message may affect the reader just as one's tone of voice affects the listener in a verbal exchange. This could influence response and completion rates. Added to the complexity, tone can be interpreted differently by different individuals. Survey communications about reminders suggest two approaches appealing to a team victory with a sense of duty and benefit for others by participating or by building a sense of encouragement for participation. In addition, we will test whether introducing duty or encouragement in the second reminder (after a generic first reminder) makes a difference and whether someone who was exposed to duty or encouragement in the first reminder benefits from the reinforcement of a "nudge" from a generic reminder.
METHODS
This research involves exploring ways to increase recruitment rates through reminder emails that will be sent to those who were invited but have not yet responded to the questionnaire. A reminder will be sent to all non-respondents by email 14 days following the initial mailing. An additional reminder will be sent to all non-respondents by email 28 days following the first reminder. The nested trial (ResponseQT) will examine the evidence of effect for tone used within the questionnaire reminder emails. The group to which a participant is randomized will determine the tone of the questionnaire reminder emails.
All potential respondents will be randomized to one of nine groups. They will receive the same questionnaire invitation email. Reminders for non-responders be assigned according to the group they were randomized to:
Group A Tone = Duty x 2
Group B Tone = Encourage x 2
Group C Tone = Encourage + Duty
Group D Tone = Duty + encourage
Group E Tone = Generic tone reminders X 2
Group F Tone = Generic + Duty
Group G Tone = Generic + Encouragement
Group H Tone = Duty + Generic
Group I Tone = Encouragement + Generic
All non-responders will receive a reminder to complete the questionnaire at fourteen days according to the group they are randomized to. At twenty-eight days remaining non-responders will receive the second reminder email.
The outcomes of recruitment will be compared at three stages: initial response, following the first reminder and following the second reminder.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oxfordshire
-
Oxford, Oxfordshire, United Kingdom, OX4 4DN
- ThinkWell
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- reports of clinical trials with human participants indexed in PubMed 2014-15
Exclusion Criteria:
- reports of laboratory or animal studies,
- reports of preclinical trials,
- reports of trials where there were no study participants
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group A Reminder
Tone of reminder email (duty 14 days followed by duty for non-responders 28 days)
|
Tone of reminder email (duty 14 days followed by duty 28 days for non-responders)
|
Active Comparator: Group B Reminder
Tone of reminder email (encouragement 14 days followed by encouragement for non-responders 28 days)
|
Tone of reminder email (encouragement 14 days followed by encouragement 28 days for non-responders)
|
Active Comparator: Group C Reminder
Tone of reminder email (encouragement 14 days followed by duty for non-responders 28 days)
|
Tone of reminder email (encouragement 14 days followed by duty for non-responders 28 days)
|
Active Comparator: Group D Reminder
Tone of reminder email (duty 14 days followed by encouragement for non-responders 28 days)
|
Tone of reminder email (duty 14 days followed by encouragement for non-responders 28 days)
|
Active Comparator: Group E Reminder
Tone of reminder email (generic reminders at 14 days followed by generic for non-responders 28 days)
|
Tone of reminder email (generic reminders 14 days followed by 28 days for non-responders)
|
Active Comparator: Group F Reminder
Tone of reminder email (generic 14 days followed by duty for non-responders 28 days)
|
Tone of reminder email (generic 14 days followed by duty for non-responders 28 days)
|
Active Comparator: Group G Reminder
Tone of reminder email (generic 14 days followed by encouragement for non-responders 28 days)
|
Tone of reminder email (generic 14 days followed by encouragement for non-responders 28 days)
|
Active Comparator: Group H Reminder
Tone of reminder email (duty 14 days followed by generic for non-responders 28 days)
|
Tone of reminder email ( duty14 days followed by generic for non-responders 28 days)
|
Active Comparator: Group I Reminder
Tone of reminder email (encouragement 14 days followed by generic for non-responders 28 days)
|
Tone of reminder email (encouragement 14 days followed by generic non-responders 28 days)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recruitment
Time Frame: Duration of study up to 60 days
|
Proportion of sample recruited
|
Duration of study up to 60 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Amy I Price, PhD, ThinkWell
Publications and helpful links
General Publications
- Wilson PM, Petticrew M, Calnan MW, Nazareth I. Disseminating research findings: what should researchers do? A systematic scoping review of conceptual frameworks. Implement Sci. 2010 Nov 22;5:91. doi: 10.1186/1748-5908-5-91.
- Tetroe JM, Graham ID, Foy R, Robinson N, Eccles MP, Wensing M, Durieux P, Legare F, Nielson CP, Adily A, Ward JE, Porter C, Shea B, Grimshaw JM. Health research funding agencies' support and promotion of knowledge translation: an international study. Milbank Q. 2008 Mar;86(1):125-55. doi: 10.1111/j.1468-0009.2007.00515.x.
- Felix LM, Burchett HE, Edwards PJ. Factorial trial found mixed evidence of effects of pre-notification and pleading on response to Web-based survey. J Clin Epidemiol. 2011 May;64(5):531-6. doi: 10.1016/j.jclinepi.2010.06.001. Epub 2010 Sep 17.
- Fang J, Shao P, Lan G. Effects of innovativeness and trust on web survey participation. Comput Human Behav 2009;25:144-52. doi:10.1016/j.chb.2008.08.002
- Fan W, Yan Z. Factors affecting response rates of the web survey: A systematic review. Comput Human Behav 2010;26:132-9. doi:10.1016/j.chb.2009.10.015
- Cook DA, Wittich CM, Daniels WL, West CP, Harris AM, Beebe TJ. Incentive and Reminder Strategies to Improve Response Rate for Internet-Based Physician Surveys: A Randomized Experiment. J Med Internet Res. 2016 Sep 16;18(9):e244. doi: 10.2196/jmir.6318.
- Baruch Y, Holtom BC. Survey response rate levels and trends in organizational research. Hum Relations 2008;61:1139-60. doi:10.1177/0018726708094863
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ThinkWell & BMJ 2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Motivation
-
Centre Hospitalier Universitaire de NiceLaboratoire Motricité Humaine, Expertise, Sport, Santé (LAMHESS); Côte d'Azur...Not yet recruiting
-
Nourhan M.AlyAlexandria UniversityCompleted
-
University of Southern DenmarkUnknown
-
University Hospital, CaenCompleted
-
University of OklahomaCompletedSmoking Cessation | MotivationUnited States
-
State University of New York at BuffaloEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Jacobs University Bremen gGmbHLiveonline CoachingCompletedMotivation | Impaired HealthGermany
-
Kahramanmaras Sutcu Imam UniversityRecruiting
Clinical Trials on Group A Reminder
-
Swiss Tropical & Public Health InstituteInnovations for Poverty ActionCompletedImmunization CoverageGhana
-
Kaiser PermanenteCompletedChronic Obstructive Pulmonary Disease | AsthmaUnited States
-
ThinkWellUniversity of Oxford; Queen's University, Belfast; The BMJCompleted
-
Sarah HufCompletedCervical Carcinoma | Cervical DysplasiaUnited Kingdom
-
Seva FoundationQueen's University, Belfast; Bharatpur Eye Hospital; Indian Institute of Public... and other collaboratorsCompletedConjunctivitis | Strabismus | Amblyopia | Corneal Ulcer | Eye Injuries | CNLDO - Congenital Nasolacrimal Duct ObstructionNepal
-
Özden LaçinCompleted
-
University Hospital, ToursCentre Régional de Coordination des Dépistages des Cancers - Centre-Val de... and other collaboratorsCompletedCervical Cancer | Cervical Cancer ScreeningFrance
-
Boehringer IngelheimCompleted
-
Chinese University of Hong KongCompleted
-
Interactive Research and DevelopmentCompletedSMS | Immunization; Infection